Present and future DNA vaccines for chronic hepatitis B treatment
Author:
Affiliation:
1. INSERM U1052, Centre de Recherche en Cancérologie de Lyon (CRCL), University Lyon 1, Lyon, France
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14712598.2017.1265940
Reference61 articles.
1. Hepatitis B Virus Infection
2. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
3. First‐line treatment of chronic hepatitis B with entecavir or tenofovir in ‘real‐life’ settings: from clinical trials to clinical practice
4. Molecular genetics of HBV infection
5. New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Elimination of the hepatitis B virus: A goal, a challenge;Medicinal Research Reviews;2024-03-25
2. Novel Therapeutic Approaches for the Management of Hepatitis Infections;Therapeutic Delivery;2024-02-27
3. Recent advances in understanding T cell activation and exhaustion during HBV infection;Virologica Sinica;2023-12
4. Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection;Biomedicines;2023-07-08
5. Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure;Drugs;2023-03-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3